BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10623815)

  • 1. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
    Kalka-Moll WM; Tzianabos AO; Wang Y; Carey VJ; Finberg RW; Onderdonk AB; Kasper DL
    J Immunol; 2000 Jan; 164(2):719-24. PubMed ID: 10623815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.
    Tzianabos AO; Onderdonk AB; Zaleznik DF; Smith RS; Kasper DL
    Infect Immun; 1994 Nov; 62(11):4881-6. PubMed ID: 7927768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses.
    Tzianabos AO; Kasper DL; Onderdonk AB
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S132-40. PubMed ID: 7548535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.
    Tzianabos AO; Gibson FC; Cisneros RL; Kasper DL
    J Infect Dis; 1998 Jul; 178(1):200-6. PubMed ID: 9652441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro.
    Brubaker JO; Li Q; Tzianabos AO; Kasper DL; Finberg RW
    J Immunol; 1999 Feb; 162(4):2235-42. PubMed ID: 9973499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zwitterionic polysaccharides stimulate T cells with no preferential V beta usage and promote anergy, resulting in protection against experimental abscess formation.
    Stingele F; Corthésy B; Kusy N; Porcelli SA; Kasper DL; Tzianabos AO
    J Immunol; 2004 Feb; 172(3):1483-90. PubMed ID: 14734725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial structure and functional relation to abscess formation.
    Tzianabos AO; Onderdonk AB; Kasper DL
    Infect Agents Dis; 1994 Oct; 3(5):256-65. PubMed ID: 7866658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.
    Chung DR; Kasper DL; Panzo RJ; Chitnis T; Grusby MJ; Sayegh MH; Tzianabos AO
    J Immunol; 2003 Feb; 170(4):1958-63. PubMed ID: 12574364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
    Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.
    Kalka-Moll WM; Wang Y; Comstock LE; Gonzalez SE; Tzianabos AO; Kasper DL
    Infect Immun; 2001 Apr; 69(4):2339-44. PubMed ID: 11254591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good and laudable pus.
    Gorbach SL
    J Clin Invest; 1995 Dec; 96(6):2545. PubMed ID: 8675616
    [No Abstract]   [Full Text] [Related]  

  • 14. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria.
    Tzianabos AO; Finberg RW; Wang Y; Chan M; Onderdonk AB; Jennings HJ; Kasper DL
    J Biol Chem; 2000 Mar; 275(10):6733-40. PubMed ID: 10702228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 mediates protection against abscess formation in an experimental model of sepsis.
    Tzianabos AO; Russell PR; Onderdonk AB; Gibson FC; Cywes C; Chan M; Finberg RW; Kasper DL
    J Immunol; 1999 Jul; 163(2):893-7. PubMed ID: 10395684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total Synthesis of Zwitterionic Tetrasaccharide Repeating Unit from Bacteroides fragilis ATCC 25285/NCTC 9343 Capsular Polysaccharide PS A1 with Alternating Charges on Adjacent Monosaccharides.
    Eradi P; Ghosh S; Andreana PR
    Org Lett; 2018 Aug; 20(15):4526-4530. PubMed ID: 30015493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides.
    Tzianabos AO; Wang JY; Lee JC
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9365-70. PubMed ID: 11470905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total synthesis of the Bacteroides fragilis zwitterionic polysaccharide A1 repeating unit.
    Pragani R; Seeberger PH
    J Am Chem Soc; 2011 Jan; 133(1):102-7. PubMed ID: 21142035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.